RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @Doc_Hieu: Oh snap! Bosch in the nicest way possible schooling Matt Williams.
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @Doc_Hieu: Oh snap! Bosch in the nicest way possible schooling Matt Williams.
Oh snap! Bosch in the nicest way possible schooling Matt Williams.
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @alphavestcap: https://t.co/9iE2VJBNNT $nwbo @alphavestcap
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
https://t.co/9iE2VJBNNT $nwbo @alphavestcap
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and misstatements in Dr. Williams argument. $NWBO
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
$NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. https://t.co/pfRDJT4azX https://t.co/bPZrGcjabh
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: @RichardRabindr2 @IntEngineering #DCVax, developed by world renowned Neurosurgeon and Chief of Neurosurgery at UCLA, L…
@RichardRabindr2 @IntEngineering #DCVax, developed by world renowned Neurosurgeon and Chief of Neurosurgery at UCLA, Linda Liau, MD, already has a successful P3 data readout in JAMA-Oncology. Quit listening to CNBC and do your homework. Geeeesh! https://t.
@stillalivejony5 @FlemmingBruce @Keubiko @bernardkeogh1 @adamfeuerstein https://t.co/8tKGOPZBEg Stick to credible sources such as JAMA Oncology, Brown University, UCLA, and King’s College. https://t.co/8tKGOPZBEg https://t.co/4M4b3STHhP
https://t.co/0DKrGOG49e https://t.co/3qgw3CUDbY https://t.co/bhUDKROm2Z $nwbo @alphavestcap
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @griffin8210: Can’t wait to see ADAM on the stand … is JAMA regarded as one of the top 5 medical journals in the world ?? Yes or No If…
RT @griffin8210: Can’t wait to see ADAM on the stand … is JAMA regarded as one of the top 5 medical journals in the world ?? Yes or No If…
RT @MonsonVO: @NobelPrize Honor these two women for their work creating and bringing an effective immunotherapy cancer drug to market. See…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @MonsonVO: @NobelPrize Honor these two women for their work creating and bringing an effective immunotherapy cancer drug to market. See…
@NobelPrize Honor these two women for their work creating and bringing an effective immunotherapy cancer drug to market. See Dr. Liau’s info at https://t.co/WnJgPtkzmA and her groundbreaking trial https://t.co/2vKkJm7A8N and Linda Powers at https://t.co/Lg
RT @sujithonco: "Adding DCVax-L to SOC was associated with a clinically meaningful and statistically significant improvement in median OS f…
RT @johnlane45: $NWBO #DCVax
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
"Adding DCVax-L to SOC was associated with a clinically meaningful and statistically significant improvement in median OS for patients with both nGBM and rGBM compared with matched, contemporaneous external controls" Did this study change practice? A 🧵 h
RT @flaskworks: @SnackBioTech @biggercapital Why diminish patients treated under UK specials? Northwest Bio was never going to reach tens…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @johnlane45: $NWBO #DCVax
RT @johnlane45: $NWBO #DCVax
RT @johnlane45: $NWBO #DCVax
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
$NWBO #DCVax
RT @flaskworks: @SnackBioTech @biggercapital Why diminish patients treated under UK specials? Northwest Bio was never going to reach tens…
@LindaGeddes "Personalised cancer jab 5 years" ?? Seems you are not up to date with #dcvax, peer-reviewed results currently in the process of submitting approval request to MHRA. UK approval just the start, will be approved in the coming months. #dcvax ht
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @flaskworks: @SnackBioTech @biggercapital Why diminish patients treated under UK specials? Northwest Bio was never going to reach tens…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
Can’t wait to see ADAM on the stand … is JAMA regarded as one of the top 5 medical journals in the world ?? Yes or No If yes .. do u believe they are printing false info regarding effectiveness of DCVAX. If yes please provide proof Game set MATCH
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
RT @metacollectiveG: $NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial pape…
$NWBO 60 plus world class Neurosurgeons signed this peer reviewed journal article; less than 8% of oncology trial papers are accepted for publication in this prestigious journal. And some little blogger thinks his snarky Tweets should be more significant.
RT @Dave46217976: @justinkeister5 Hahaha Adam F (a political science major) vs 70 physicians and scientists authoring a peer reviewed artic…
RT @Dave46217976: @justinkeister5 Hahaha Adam F (a political science major) vs 70 physicians and scientists authoring a peer reviewed artic…
RT @Dave46217976: @justinkeister5 Hahaha Adam F (a political science major) vs 70 physicians and scientists authoring a peer reviewed artic…
@justinkeister5 Hahaha Adam F (a political science major) vs 70 physicians and scientists authoring a peer reviewed article in JAMA. https://t.co/nXbv0tTX84
RT @flaskworks: @Keubiko @MidwestHedgie @adamfeuerstein Asking the wrong people about $NWBO which published groundbreaking results for a di…
RT @flaskworks: @Keubiko @MidwestHedgie @adamfeuerstein Asking the wrong people about $NWBO which published groundbreaking results for a di…
@LisainNJUSA @GaryGensler Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial https://
RT @apwriter: $nwbo
RT @ttk0333: @elonmusk https://t.co/iKMIe4SyXA The medical world shall soon embrace a new era in treating tumor cancers with personalised v…
$nwbo